Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications
Top Cited Papers
- 4 January 2025
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 50 (1) , 21-33
- https://doi.org/10.1016/s0031-6997(24)01347-4
Abstract
No abstract availableThis publication has 148 references indexed in Scilit:
- Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled TrialAnnals of Internal Medicine, 1993
- The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemiaAnnals of Neurology, 1986
- Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trialDiabetologia, 1985
- Nonenzymatic Glycosylation and the Pathogenesis of Diabetic ComplicationsAnnals of Internal Medicine, 1984
- RCapillaries: Basement Membrane Thickening by Galactosemia Prevented with Aldose Reductase InhibitorScience, 1983
- Aldose and Aldehyde Reductase Exhibit Isocorticosteroid Reductase ActivityEuropean Journal of Biochemistry, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- Purification and Characterization of Human‐Brain Aldose ReductaseEuropean Journal of Biochemistry, 1982
- Lipid peroxide level in plasma of diabetic patientsBiochemical Medicine, 1979
- Nonenzymatic glycosylation of hemoglobin.Journal of Biological Chemistry, 1977